Matthew Trerotola - Enovis Corp Chief Executive Officer, Director

ENOV Stock  USD 48.81  0.36  0.74%   

CEO

Matthew Trerotola is Chief Executive Officer, Director of Enovis Corp since 2021.
Age 57
Tenure 3 years
Address 2711 Centerville Road, Wilmington, DE, United States, 19808
Phone302 252 9160
Webhttps://www.enovis.com

Enovis Corp Management Efficiency

Return On Tangible Assets is likely to climb to -0.02 in 2024. Return On Capital Employed is likely to climb to -0.02 in 2024. At this time, Enovis Corp's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 1.3 B in 2024, whereas Non Currrent Assets Other are likely to drop slightly above 85.7 M in 2024. Enovis Corp's management efficiency ratios could be used to measure how well Enovis Corp manages its routine affairs as well as how well it operates its assets and liabilities.
Enovis Corp currently holds 536.42 M in liabilities with Debt to Equity (D/E) ratio of 0.15, which may suggest the company is not taking enough advantage from borrowing. Enovis Corp has a current ratio of 1.3, suggesting that it is not liquid enough and may have problems paying out its financial obligations when due. Note, when we think about Enovis Corp's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 10 records

CEO Age

James LinesGraham
59
Gregory VolovicHurco Companies
59
Josef MatosevicHelios Technologies
53
Joseph RuzynskiFranklin Electric Co
48
Paul SternliebEnerpac Tool Group
52
Marvin RileyEnpro Industries
45
Dean RivestOmega Flex
53
Randal BakerEnerpac Tool Group
56
Jeffrey PowellKadant Inc
65
Timothy CPAMiddleby Corp
54
Enovis Corporation operates as a medical technology company worldwide. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies and directly under the DJO brand. Enovis Corp operates under Specialty Industrial Machinery classification in the United States and is traded on New York Stock Exchange. It employs 16200 people. Enovis Corp (ENOV) is traded on New York Stock Exchange in USA. It is located in 2711 Centerville Road, Wilmington, DE, United States, 19808 and employs 6,550 people. Enovis Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Enovis Corp Leadership Team

Elected by the shareholders, the Enovis Corp's board of directors comprises two types of representatives: Enovis Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Enovis. The board's role is to monitor Enovis Corp's management team and ensure that shareholders' interests are well served. Enovis Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Enovis Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael Macek, VP Relations
Angela Lalor, Director
John Kleckner, Principal Officer
Bradley Tandy, Senior Vice President General Counsel, Corporate Secretary
Christopher Hix, Chief Financial Officer, Executive Vice President - Finance
Phillip Berry, Senior CFO
Liam Kelly, Independent Director
Rajiv Vinnakota, Independent Director
Derek JD, Vice Relations
Louie Vogt, Group Reconstructive
A Perfall, Independent Director
Brian Hanigan, Secretary
Patricia Lang, Chief Human Resource Officer, Senior Vice President
Mitchell Rales, Chairman of the Board
Christine Ortiz, Director
Terry Ross, Group Recovery
Sharon Wienbar, Independent Director
Katie Sweet, Vice Communication
Derek Leckow, Vice Relations
Barbara Bodem, Director
Bradley JD, Senior Officer
Philip Okala, Independent Director
Brady Shirley, President, Chief Operating Officer, Director
Matthew Trerotola, Chief Executive Officer, Director
Tim Czartoski, President Technologies
Daniel Pryor, Executive Vice President - Strategy and Business Development
Shyam Kambeyanda, Executive Vice President, President and Chief Executive Officer of ESAB

Enovis Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Enovis Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Enovis Stock Analysis

When running Enovis Corp's price analysis, check to measure Enovis Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enovis Corp is operating at the current time. Most of Enovis Corp's value examination focuses on studying past and present price action to predict the probability of Enovis Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enovis Corp's price. Additionally, you may evaluate how the addition of Enovis Corp to your portfolios can decrease your overall portfolio volatility.